New Analyst Forecast: $CSX Given 'Overweight' Rating

We just received data on a new analyst forecast for $CSX. Barclays gave a rating of 'Overweight' for $CSX.

$CSX Analyst Ratings

Wall Street analysts have issued reports on $CSX in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

• Barclays issued a "Overweight" rating on 04/02/2025
• Susquehanna issued a "Positive" rating on 03/27/2025
• Citigroup issued a "Buy" rating on 01/24/2025
• Jefferies issued a "Buy" rating on 01/10/2025
• BMO Capital issued a "Outperform" rating on 10/17/2024
• Evercore ISI issued a "Outperform" rating on 10/17/2024

To track analyst ratings and price targets for $CSX, check out Quiver Quantitative's $CSX forecast page.

$CSX Price Targets

Multiple analysts have issued price targets for $CSX recently. We have seen 9 analysts offer price targets for $CSX in the last 6 months, with a median target of $37.0.

Here are some recent targets:

• Bascome Majors from Susquehanna set a target price of $37.0 on 03/27/2025
• An analyst from Deutsche Bank set a target price of $34.0 on 03/07/2025
• Rick Paterson from Loop Capital Markets set a target price of $34.0 on 02/03/2025
• Walter Spracklin from RBC Capital set a target price of $35.0 on 10/17/2024
• Christian Wetherbee from Wells Fargo set a target price of $34.0 on 10/17/2024
• Stephanie Moore from Jefferies set a target price of $37.0 on 10/17/2024
• Fadi Chamoun from BMO Capital set a target price of $39.0 on 10/17/2024

$CSX Congressional Stock Trading

Members of Congress have traded $CSX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $CSX stock by members of Congress over the last 6 months:

• REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 02/25.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$CSX Insider Trading Activity

$CSX insiders have traded $CSX stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $CSX stock by insiders over the last 6 months:

• NATHAN D GOLDMAN (EVP & CLO) has made 0 purchases and 2 sales selling 118,588 shares for an estimated $4,197,315.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$CSX Hedge Fund Activity

We have seen 663 institutional investors add shares of $CSX stock to their portfolio, and 722 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

• JPMORGAN CHASE & CO added 16,687,596 shares (+18.4%) to their portfolio in Q4 2024, for an estimated $538,508,722
• AMERIPRISE FINANCIAL INC added 9,863,587 shares (+89.7%) to their portfolio in Q4 2024, for an estimated $318,297,952
• PRICE T ROWE ASSOCIATES INC /MD/ removed 7,961,244 shares (-13.7%) from their portfolio in Q4 2024, for an estimated $256,909,343
• BANK OF NEW YORK MELLON CORP added 6,730,316 shares (+40.5%) to their portfolio in Q4 2024, for an estimated $217,187,297
• CAPITAL WORLD INVESTORS removed 6,493,505 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $209,545,406
• MITSUBISHI UFJ TRUST & BANKING CORP added 5,568,624 shares (+471.9%) to their portfolio in Q4 2024, for an estimated $179,699,496
• FIDUCIARY MANAGEMENT INC /WI/ added 5,523,970 shares (+inf%) to their portfolio in Q4 2024, for an estimated $178,258,511

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.